Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptides | 19 | 2016 | 372 | 4.050 |
Why?
|
| Nanotechnology | 14 | 2010 | 176 | 2.270 |
Why?
|
| Nanotubes, Peptide | 6 | 2010 | 6 | 1.740 |
Why?
|
| Crystallization | 12 | 2010 | 88 | 1.370 |
Why?
|
| Ferric Compounds | 3 | 2022 | 62 | 1.370 |
Why?
|
| Biomimetic Materials | 6 | 2010 | 24 | 1.320 |
Why?
|
| Nanoparticles | 8 | 2018 | 460 | 1.270 |
Why?
|
| Nanotubes | 5 | 2008 | 17 | 1.250 |
Why?
|
| Metal Nanoparticles | 5 | 2019 | 230 | 1.110 |
Why?
|
| Lead | 3 | 2015 | 100 | 1.020 |
Why?
|
| Gold | 8 | 2010 | 156 | 1.020 |
Why?
|
| Nanostructures | 5 | 2014 | 161 | 0.930 |
Why?
|
| Transducers | 3 | 2009 | 14 | 0.930 |
Why?
|
| Immunoglobulin G | 4 | 2008 | 259 | 0.890 |
Why?
|
| Biosensing Techniques | 4 | 2010 | 136 | 0.880 |
Why?
|
| Selenium Compounds | 2 | 2015 | 11 | 0.790 |
Why?
|
| Hyperthermia, Induced | 1 | 2022 | 28 | 0.760 |
Why?
|
| Zinc Oxide | 3 | 2011 | 25 | 0.690 |
Why?
|
| Proteins | 3 | 2018 | 382 | 0.670 |
Why?
|
| Semiconductors | 3 | 2010 | 12 | 0.660 |
Why?
|
| Microscopy, Atomic Force | 7 | 2015 | 61 | 0.630 |
Why?
|
| Silicon | 2 | 2009 | 17 | 0.610 |
Why?
|
| Nanowires | 2 | 2010 | 9 | 0.590 |
Why?
|
| Immunoassay | 2 | 2009 | 74 | 0.590 |
Why?
|
| Sulfides | 2 | 2010 | 78 | 0.530 |
Why?
|
| Viruses | 2 | 2008 | 39 | 0.530 |
Why?
|
| Surface Properties | 7 | 2014 | 160 | 0.520 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 367 | 0.510 |
Why?
|
| Dextrans | 1 | 2016 | 29 | 0.510 |
Why?
|
| Collagen | 4 | 2015 | 181 | 0.500 |
Why?
|
| Temperature | 5 | 2015 | 313 | 0.490 |
Why?
|
| Crows | 1 | 2016 | 1 | 0.490 |
Why?
|
| Tool Use Behavior | 1 | 2016 | 2 | 0.490 |
Why?
|
| Beak | 1 | 2016 | 8 | 0.490 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 495 | 0.480 |
Why?
|
| Silicic Acid | 1 | 2015 | 1 | 0.470 |
Why?
|
| Water | 3 | 2014 | 316 | 0.470 |
Why?
|
| Antibodies | 2 | 2007 | 144 | 0.470 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 220 | 0.460 |
Why?
|
| Drug Carriers | 1 | 2016 | 174 | 0.450 |
Why?
|
| Palladium | 2 | 2016 | 30 | 0.450 |
Why?
|
| Bacteriophage M13 | 1 | 2014 | 2 | 0.450 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 15 | 0.440 |
Why?
|
| Quantum Dots | 1 | 2015 | 38 | 0.440 |
Why?
|
| Biocatalysis | 1 | 2014 | 30 | 0.440 |
Why?
|
| Protons | 1 | 2015 | 94 | 0.440 |
Why?
|
| Amino Acid Sequence | 7 | 2016 | 1180 | 0.430 |
Why?
|
| Biomimetics | 2 | 2012 | 15 | 0.410 |
Why?
|
| Ovarian Neoplasms | 2 | 2025 | 415 | 0.400 |
Why?
|
| Behavior, Animal | 1 | 2016 | 373 | 0.390 |
Why?
|
| Energy Transfer | 1 | 2012 | 32 | 0.380 |
Why?
|
| Phenylalanine | 1 | 2012 | 25 | 0.380 |
Why?
|
| Peptide Fragments | 2 | 2016 | 307 | 0.380 |
Why?
|
| Capsules | 1 | 2012 | 28 | 0.370 |
Why?
|
| Silver | 2 | 2010 | 61 | 0.350 |
Why?
|
| Urease | 2 | 2009 | 16 | 0.350 |
Why?
|
| Escherichia coli | 2 | 2014 | 460 | 0.340 |
Why?
|
| Mollusca | 1 | 2010 | 17 | 0.320 |
Why?
|
| Organometallic Compounds | 2 | 2014 | 71 | 0.320 |
Why?
|
| Cell Separation | 1 | 2009 | 94 | 0.310 |
Why?
|
| Motion | 2 | 2022 | 31 | 0.310 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2015 | 160 | 0.310 |
Why?
|
| Calmodulin | 1 | 2009 | 47 | 0.300 |
Why?
|
| Oligopeptides | 2 | 2014 | 109 | 0.300 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 49 | 0.300 |
Why?
|
| Microbial Viability | 1 | 2009 | 42 | 0.300 |
Why?
|
| Titanium | 2 | 2015 | 48 | 0.300 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 108 | 0.290 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 80 | 0.290 |
Why?
|
| Histidine | 3 | 2003 | 43 | 0.290 |
Why?
|
| Molecular Conformation | 4 | 2010 | 155 | 0.290 |
Why?
|
| Riluzole | 2 | 2019 | 6 | 0.280 |
Why?
|
| Particle Size | 5 | 2014 | 272 | 0.280 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2007 | 2 | 0.280 |
Why?
|
| Electric Capacitance | 1 | 2007 | 7 | 0.280 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2005 | 20 | 0.270 |
Why?
|
| Aniline Compounds | 1 | 2008 | 28 | 0.270 |
Why?
|
| Materials Testing | 4 | 2010 | 101 | 0.270 |
Why?
|
| Copper | 2 | 2012 | 134 | 0.270 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 27 | 0.270 |
Why?
|
| Pyrroles | 1 | 2008 | 72 | 0.270 |
Why?
|
| Antigen-Antibody Complex | 1 | 2007 | 20 | 0.270 |
Why?
|
| Biopolymers | 1 | 2007 | 17 | 0.270 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 2676 | 0.260 |
Why?
|
| Gallium | 1 | 2007 | 2 | 0.260 |
Why?
|
| Catalysis | 4 | 2016 | 187 | 0.260 |
Why?
|
| Minerals | 1 | 2007 | 53 | 0.260 |
Why?
|
| Polymers | 1 | 2008 | 155 | 0.250 |
Why?
|
| Zinc Compounds | 1 | 2005 | 12 | 0.240 |
Why?
|
| Zinc Fingers | 1 | 2005 | 28 | 0.240 |
Why?
|
| Enzymes, Immobilized | 1 | 2005 | 13 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 63 | 0.230 |
Why?
|
| Antigens | 1 | 2005 | 59 | 0.230 |
Why?
|
| Antibodies, Immobilized | 3 | 2009 | 8 | 0.220 |
Why?
|
| Protein Folding | 1 | 2005 | 123 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2025 | 968 | 0.220 |
Why?
|
| Protein Multimerization | 2 | 2016 | 115 | 0.220 |
Why?
|
| Macromolecular Substances | 3 | 2010 | 92 | 0.210 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2016 | 13 | 0.210 |
Why?
|
| Animals | 11 | 2025 | 16992 | 0.210 |
Why?
|
| alpha-Cyclodextrins | 1 | 2003 | 1 | 0.210 |
Why?
|
| Cyclodextrins | 1 | 2003 | 11 | 0.200 |
Why?
|
| Azo Compounds | 1 | 2003 | 17 | 0.200 |
Why?
|
| Macrocyclic Compounds | 1 | 2003 | 12 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2007 | 388 | 0.200 |
Why?
|
| Nanotubes, Carbon | 1 | 2004 | 87 | 0.200 |
Why?
|
| Genome, Human | 1 | 2003 | 144 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 307 | 0.190 |
Why?
|
| Protein Conformation | 4 | 2015 | 416 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1723 | 0.190 |
Why?
|
| Humans | 16 | 2025 | 43102 | 0.190 |
Why?
|
| Pneumonectomy | 1 | 2021 | 10 | 0.180 |
Why?
|
| Mice | 7 | 2025 | 6644 | 0.180 |
Why?
|
| Sulfhydryl Compounds | 2 | 2016 | 51 | 0.170 |
Why?
|
| Nitrogen Dioxide | 1 | 2020 | 17 | 0.170 |
Why?
|
| Thymoma | 1 | 2020 | 2 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 436 | 0.160 |
Why?
|
| Hydrogen Bonding | 2 | 2015 | 144 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 734 | 0.160 |
Why?
|
| Air Pollution | 1 | 2020 | 87 | 0.160 |
Why?
|
| Osteosarcoma | 1 | 2019 | 30 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 90 | 0.150 |
Why?
|
| Electrodes | 2 | 2009 | 59 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 49 | 0.150 |
Why?
|
| Air Pollutants | 1 | 2020 | 130 | 0.150 |
Why?
|
| Solutions | 2 | 2010 | 65 | 0.150 |
Why?
|
| Melanoma | 1 | 2020 | 110 | 0.150 |
Why?
|
| Environmental Monitoring | 1 | 2020 | 230 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 186 | 0.150 |
Why?
|
| Lung | 1 | 2021 | 492 | 0.140 |
Why?
|
| Cell Fractionation | 1 | 2018 | 29 | 0.140 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1542 | 0.130 |
Why?
|
| Mutation | 2 | 2015 | 1177 | 0.130 |
Why?
|
| Female | 7 | 2025 | 24698 | 0.130 |
Why?
|
| Diazonium Compounds | 1 | 2016 | 1 | 0.120 |
Why?
|
| Enzymes | 1 | 2016 | 35 | 0.120 |
Why?
|
| Exosomes | 1 | 2018 | 126 | 0.120 |
Why?
|
| Photochemical Processes | 1 | 2015 | 19 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2016 | 49 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 87 | 0.120 |
Why?
|
| Catalytic Domain | 1 | 2016 | 118 | 0.120 |
Why?
|
| Cesium | 1 | 2015 | 8 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 127 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 61 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 296 | 0.110 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 64 | 0.110 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 16 | 0.110 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 61 | 0.110 |
Why?
|
| Heme | 1 | 2015 | 72 | 0.110 |
Why?
|
| Friction | 1 | 2014 | 6 | 0.110 |
Why?
|
| Surface Tension | 1 | 2014 | 12 | 0.110 |
Why?
|
| Anisotropy | 1 | 2014 | 33 | 0.110 |
Why?
|
| Graphite | 1 | 2016 | 64 | 0.110 |
Why?
|
| Amyloid | 1 | 2015 | 65 | 0.110 |
Why?
|
| Protein Binding | 2 | 2009 | 1082 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2009 | 876 | 0.110 |
Why?
|
| Porosity | 1 | 2014 | 43 | 0.110 |
Why?
|
| Binding Sites | 2 | 2009 | 671 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2014 | 97 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 245 | 0.110 |
Why?
|
| Carbon | 1 | 2015 | 128 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 188 | 0.110 |
Why?
|
| Drug Design | 1 | 2016 | 186 | 0.110 |
Why?
|
| Equipment Design | 1 | 2014 | 145 | 0.110 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 22 | 0.110 |
Why?
|
| Elasticity | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cell Size | 1 | 2014 | 46 | 0.110 |
Why?
|
| Micelles | 1 | 2014 | 36 | 0.110 |
Why?
|
| Herbal Medicine | 1 | 2014 | 8 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 1092 | 0.110 |
Why?
|
| Amides | 1 | 2014 | 71 | 0.100 |
Why?
|
| Aged | 3 | 2021 | 8214 | 0.100 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 118 | 0.100 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2003 | 104 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 117 | 0.100 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 210 | 0.100 |
Why?
|
| Thermodynamics | 1 | 2014 | 229 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 201 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 237 | 0.100 |
Why?
|
| Microtechnology | 1 | 2012 | 5 | 0.100 |
Why?
|
| Dipeptides | 1 | 2012 | 31 | 0.100 |
Why?
|
| Oils | 1 | 2012 | 6 | 0.090 |
Why?
|
| Biological Products | 1 | 2014 | 91 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 256 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2014 | 403 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 347 | 0.090 |
Why?
|
| Japan | 2 | 2020 | 348 | 0.090 |
Why?
|
| Peptide Library | 1 | 2011 | 28 | 0.090 |
Why?
|
| Streptavidin | 1 | 2010 | 6 | 0.080 |
Why?
|
| Biotin | 1 | 2010 | 24 | 0.080 |
Why?
|
| Alkanesulfonic Acids | 1 | 2010 | 9 | 0.080 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 66 | 0.080 |
Why?
|
| Morpholines | 1 | 2010 | 72 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 529 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2009 | 219 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 117 | 0.070 |
Why?
|
| Electric Conductivity | 1 | 2008 | 55 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 611 | 0.070 |
Why?
|
| Microelectrodes | 1 | 2007 | 22 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1019 | 0.070 |
Why?
|
| Platinum | 1 | 2007 | 23 | 0.070 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2007 | 22 | 0.070 |
Why?
|
| Adsorption | 1 | 2007 | 74 | 0.070 |
Why?
|
| Capsid Proteins | 1 | 2007 | 76 | 0.070 |
Why?
|
| Capsid | 1 | 2007 | 65 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 209 | 0.060 |
Why?
|
| Bacteria | 1 | 2010 | 293 | 0.060 |
Why?
|
| Circular Dichroism | 1 | 2007 | 64 | 0.060 |
Why?
|
| Dimerization | 1 | 2007 | 112 | 0.060 |
Why?
|
| Neoplasms | 1 | 2018 | 1377 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2007 | 204 | 0.060 |
Why?
|
| Ligands | 1 | 2007 | 388 | 0.060 |
Why?
|
| Lipase | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2025 | 56 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 19 | 0.060 |
Why?
|
| Candida | 1 | 2005 | 42 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 184 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 462 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2004 | 83 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 159 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 12 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2005 | 190 | 0.050 |
Why?
|
| Kinetics | 1 | 2005 | 695 | 0.050 |
Why?
|
| Phenotype | 2 | 2018 | 780 | 0.050 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2003 | 31 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 31 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 61 | 0.050 |
Why?
|
| Pedigree | 1 | 2003 | 94 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2025 | 456 | 0.050 |
Why?
|
| Siblings | 1 | 2003 | 22 | 0.050 |
Why?
|
| Ethers, Cyclic | 1 | 2003 | 5 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 71 | 0.050 |
Why?
|
| Photochemistry | 1 | 2003 | 57 | 0.050 |
Why?
|
| Crystallography | 1 | 2003 | 8 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2003 | 18 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 199 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 52 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 2853 | 0.040 |
Why?
|
| Nitrous Acid | 1 | 2020 | 2 | 0.040 |
Why?
|
| Tokyo | 1 | 2020 | 5 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 57 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 60 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 238 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 84 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 93 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 408 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 13 | 0.030 |
Why?
|
| Glycomics | 1 | 2018 | 8 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2018 | 40 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 346 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 934 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 113 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 240 | 0.030 |
Why?
|
| Metabolomics | 1 | 2018 | 95 | 0.030 |
Why?
|
| Male | 3 | 2020 | 23409 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 187 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 945 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 67 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2015 | 5 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 266 | 0.030 |
Why?
|
| Hydrogen | 1 | 2016 | 47 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2015 | 55 | 0.030 |
Why?
|
| Biomass | 1 | 2015 | 68 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 378 | 0.030 |
Why?
|
| Light | 1 | 2015 | 185 | 0.030 |
Why?
|
| DNA | 1 | 2018 | 592 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 457 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1455 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2015 | 210 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 12222 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1869 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 13872 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 5080 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2157 | 0.020 |
Why?
|